HUM vs CNC — Key Metrics
| Metric | HUM (HUMANA INC) | CNC (CENTENE CORP) |
|---|---|---|
| Price | 385.78 | 67.45 |
| Market Cap | 46.33 Billion | 33.39 Billion |
| P/E (TTM) | 37.17 | 22.79 |
| P/B (Quarterly) | 2.767 | 1.532 |
| P/S (TTM) | 0.3 | 0.16 |
| Net Profit Margin (TTM) | 0.8 | 0.7 |
| Gross Margin (TTM) | 13.0 | 7.8 |
| ROE (TTM) | 6.7 | 6.8 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Greatly Outperform
Recommendation Summary
Stock HUM is projected to outperform the market, stock CNC is projected to greatly outperform the market. Upfront Recommendation: CNC.
Financial Metrics
| HUM | Metrics | CNC |
|---|---|---|
| $385.78 | Price | $67.45 |
| — | Market Capitalization | — |
| 37.17 | Price to Earnings Ratio | 22.79 |
| 0.3 | Price to Sales | 0.16 |
| 14.65 | Price to FCF Ratio | 8.47 |
| 2.31 | Price to Gross Profit | 2.11 |
| 1.17 | Price to Current Assets | 0.73 |
HUM vs CNC at a glance
Humana INC (HUM) and Centene Corp (CNC) are both Healthcare Plans companies in the Healthcare sector. HUM is the larger, at $46.3 billion in market value against $33.4 billion for CNC, about 1.4 times the size.
On trailing-twelve-month figures, HUM trades at 37.2 times trailing earnings and CNC at 22.8; net profit margins are 0.8% and 0.7%.
The Upfront Investment model currently rates HUM Outperform and CNC Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.